Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270099 · ClinicalTrials.gov registry record
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
A clinical trial, sponsored by Hologic.
- Completed
- Registry status
- 839
- Enrollment target
NCT02270099 is a clinical trial that has completed, run by Hologic. The registered enrollment target is 839 participants.
The verdict
NCT02270099 has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- 839 participants
- Enrollment target
Study Summary
This clinical performance study is being conducted to evaluate the performance of the Aptima Herpes Simplex Viruses 1 \& 2 assay for detection of herpes simplex virus (HSV) type 1 (HSV-1) and HSV type 2 (HSV-2) in swab samples prospectively collected from suspected HSV lesions. Specimens collected using swabs from viral transport medium (VTM)collection kits and Aptima swab collection kits will be evaluated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 839 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270099
The ClinicalTrials.gov registry entry for NCT02270099 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 839 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02270099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02270099 about?
NCT02270099 is a clinical study titled "Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects". This clinical performance study is being conducted to evaluate the performance of the Aptima Herpes Simplex Viruses 1 \& 2 assay for detection of herpes simplex virus (HSV) type 1 (HSV-1) and HSV type 2 (HSV-2) in swab samples prospectively collected from suspected HSV lesions. Specimens collected u...
What is the current status of trial NCT02270099?
This trial is currently completed. The enrollment target is 839 participants. The study started on 2014-12. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT02270099?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.